Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APL180 in Familial Hypercholesterolemia
NCT00751608Phase 2Withdrawn
- Sponsor
- Novartis
- Start
- Sep 2006
- Primary completion
- Feb 2009
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 2 trial of APL180 in familial hypercholesterolemia (FH), sponsored by Novartis. Planned start Sep 2006; status: withdrawn.
02
Drugs
APL180
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on NCT00751608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751608.